Health Care
In Q2 FY2026, Baxter International reported a 5.3% YoY revenue increase to $2.96B and a 38.5% surge in net income to $126M, supported by segment realignments and $75M in tariff refund credits.
Key risk: Product Recall and Regulatory Approval Exposure
Ongoing Class I recalls and the voluntary shipment hold on the Novum IQ LVP could lead to customer defections, increased remediation expenses, and prolonged regulatory delays before normal sales resume.
Other Health Care Equipment companies